Difficulty: Medium
Average Score: 64%
Practice
Which of the following medications is commonly used to treat type 2 diabetes mellitus by increasing insulin secretion?
Correct answer
B
Rationale
In the context of pharmacological lifespan treatment for type 2 diabetes mellitus, the correct answer to the question is B) Sulfonylureas. Sulfonylureas work by stimulating insulin secretion from the beta cells of the pancreas. This mechanism of action helps to lower blood glucose levels by increasing the amount of insulin available to facilitate glucose uptake by cells.
Metformin (Option A) is commonly used as a first-line therapy for type 2 diabetes. It works by reducing glucose production in the liver and improving insulin sensitivity in the body, rather than by directly increasing insulin secretion.
Insulin glargine (Option C) is a long-acting insulin analog used to manage diabetes by providing a baseline level of insulin throughout the day. It does not increase insulin secretion like sulfonylureas.
Acarbose (Option D) is an alpha-glucosidase inhibitor that works by slowing down the digestion of carbohydrates in the intestines, thereby reducing the rise in blood glucose levels after meals. It does not directly impact insulin secretion.
It is important for healthcare providers to understand the mechanisms of action of different medications used to treat type 2 diabetes to make informed decisions in managing patients' conditions effectively. Educating patients about their medications and how they work can also improve treatment adherence and outcomes.
Metformin (Option A) is commonly used as a first-line therapy for type 2 diabetes. It works by reducing glucose production in the liver and improving insulin sensitivity in the body, rather than by directly increasing insulin secretion.
Insulin glargine (Option C) is a long-acting insulin analog used to manage diabetes by providing a baseline level of insulin throughout the day. It does not increase insulin secretion like sulfonylureas.
Acarbose (Option D) is an alpha-glucosidase inhibitor that works by slowing down the digestion of carbohydrates in the intestines, thereby reducing the rise in blood glucose levels after meals. It does not directly impact insulin secretion.
It is important for healthcare providers to understand the mechanisms of action of different medications used to treat type 2 diabetes to make informed decisions in managing patients' conditions effectively. Educating patients about their medications and how they work can also improve treatment adherence and outcomes.